Ionis Pharmaceuticals (IONS) Work In Process (2019 - 2025)

Ionis Pharmaceuticals' Work In Process history runs 7 years deep, the most recent figure standing at $8.7 million for Q1 2025.

• On a quarterly basis, Work In Process rose 44.84% year-over-year to $8.7 million in Q1 2025; TTM through Mar 2025 was $8.7 million, a 44.84% increase from a year earlier, with the FY2024 full-year figure at $6.7 million, up 21.95% from the prior year.
• Work In Process climbed to $8.7 million in Q1 2025 per IONS's latest filing, from $6.7 million in the prior quarter.
• Across five years, Work In Process topped out at $8.7 million in Q1 2025 and bottomed at $954000.0 in Q2 2021.
• The 5-year median for Work In Process is $3.9 million (2022), against an average of $4.4 million.
• Across the five-year window, Work In Process sank 72.52% in 2021 and soared 311.64% in 2022, its largest moves.
• Year by year, Work In Process stood at $5.8 million in 2021, then plunged by 63.45% to $2.1 million in 2022, then jumped by 159.7% to $5.5 million in 2023, then increased by 21.95% to $6.7 million in 2024, then surged by 30.92% to $8.7 million in 2025.
• Per Business Quant, the three latest IONS Work In Process figures stand at $8.7 million (Q1 2025), $6.7 million (Q4 2024), and $6.7 million (Q3 2024).